TickerFacts.

Meihua International Medical Technologies Co., Ltd. (MHUAF): Operating Income

Annual figures by period end, from SEC filings.

$8.28M
Year ended 2025-12-31
-8.5%
3-year compound annual growth
-18.8%
5-year compound annual growth
$26.26M2019-12-31: $19.39M2020-12-31: $23.47M2021-12-31: $26.26M2022-12-31: $10.80M2023-12-31: $14.67M2024-12-31: $14.31M2025-12-31: $8.28M$8.28M
2019-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$8.28M-42.1%2026-04-29, From 2025-01-01
2024-12-31$14.31M-2.5%2026-04-29, From 2024-01-01
2023-12-31$14.67M+35.9%2026-04-29, From 2023-01-01
2022-12-31$10.80M-58.9%2025-04-25, From 2022-01-01
2021-12-31$26.26M+11.9%2024-04-24, From 2021-01-01
2020-12-31$23.47M+21.0%2023-08-29, From 2020-01-01
2019-12-31$19.39Mn/a2022-07-29, From 2019-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$8.28M-42.1%
LENSAR, Inc. (LNSR)2025-12-31-$24.58Mn/m
CVRx, Inc. (CVRX)2025-12-31-$51.27Mn/m
AVITA Medical, Inc. (RCEL)2025-12-31-$42.53Mn/m
Apyx Medical Corp (APYX)2025-12-31-$6.45Mn/m
Carlsmed, Inc. (CARL)2025-12-31-$30.57Mn/m
Sight Sciences, Inc. (SGHT)2025-12-31-$37.10Mn/m
PRO DEX Inc (PDEX)2026-06-30$12.99M+21.5%
TELA Bio, Inc. (TELA)2025-12-31-$33.76Mn/m

Compare MHUAF, LNSR, CVRX, RCEL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗